Category: Finance
Neurotech’s Phase 2/3 autism trial meets primary endpoint
Neurotech Phase 2/3 NTIASD trial in autism spectrum disorder meets primary endpoint Study showed a statistically significant improvement in severity of illness in paediatric patients [more…]
Long Shortz with Maronan Metals: Metallurgy serves success on a silver platter
Stockhead’s Sarah Hughan sits down with Maronan Metals (ASX:MMA) managing director Richard Carlton to get the short end of the long story on the company’s latest [more…]
Challenges Ahead: Sheila Bair on Regional Bank Vulnerabilities
As regional banks prepare to unveil their quarterly earnings, concerns loom about potential vulnerabilities within the sector. Sheila Bair, the former U.S. Federal Deposit Insurance [more…]
Monsters of Rock: EVN in a race to meet ambitious gold targets but with prices where they are does it even matter?
Evolution continues to believe it can meet an ambitious gold target despite needing to produce at a near million ounce run rate in the [more…]
Salt Bae: Altech to raise $5m for groundbreaking battery tech based off common table salt
Share Purchase Plan (SPP) initiated to raise up to $5m for CERENERGY® battery and Silumina Anodes projects The battery tech uses regular table salt Funds [more…]
Closing Bell: ASX selloff softens… then pummels again last minute; Rinehart ups stake in Lynas
The ASX rebounded from a sluggish start… but wait, it all dipped again as we were heading out the door Local traders were initially shaken [more…]
Neurotech reports positive top-line Phase 1/2 Rett Syndrome clinical trial results
Neurotech’s NTIRTT1 becomes first clinical trial to show statistically significant clinical improvement in Rett Syndrome patients with a broad-spectrum cannabinoid drug Company’s NTI164 compares favourably [more…]
Pantera Minerals seizes opportunity amidst growing US lithium demand
A further 1500 acres within core Smackover lithium-brine project area acquired Total net leased acreage now over 18,570 acres – on its way to 20,000-acre [more…]
ASX Small Caps Lunch Wrap: Whose head’s gonna roll over this week’s Chinese blunder?
Local markets are up and down like a bare bum in the back of a kombi, as the ASX 200 benchmark struggles to decide which [more…]
Resources Top 5: Graphite player Renascor gets some Albo love, to the tune of $185m
Graphite miner Renascor benefits big time from Aussie gov’s critical minerals focus Meanwhile iron ore juniors Akora and Burley are capital raising… … and Nexus [more…]
